Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly

Alzheimer Disease and Associated Disorders

Volumn 12, Issue 1, 1998, Pages 33-39

  Warzok, Rolf W ^a   Kassler, Christof ^a   Apel, Gabi ^a   Schwarz, Anja ^a   Egensperger, Rupert ^b   Schreiber, Dieter ^c   Herbst, Eberhard W ^d   Wolf, Eduard ^e   Walther, Reinhard ^a   Walker, Lary C ^a,f  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Sports Clinic Erfurt   (Germany)

^d Neurologic Clinic Neubrandenburg   (Germany)

^e Stralsund Zoo   (Germany)

^f PFIZER INC   (United States)

Author keywords

Aging; Alzheimer disease; Amyloid; Amyloid angiopathy; Apolipoprotein E; Neurofibrillary tangles; Senile plaques

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN CORTEX; CONTROLLED STUDY; EUROPE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GERMANY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NORTH AMERICA; ONSET AGE; PRIORITY JOURNAL; RISK; SENILE PLAQUE; VASCULAR AMYLOIDOSIS;

EID: 0032457459     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199803000-00005     Document Type: Article

References (47)

1. Berr C, Hauw J-J, Delaère P, Duyckaerts C, Amouyel P. Apolipoprotein E allele 4 is linked to increased deposition of the amyloid β-peptide (A-β) in cases with or without Alzheimer's disease. Neurosci Lett 1994;178:221-4.
2. Blesa R, Adroer R, Santacruz P, Ascaso C, Tolosa E, Oliva R. High apolipoprotein E ∈4 allele frequency in age-related memory decline. Ann Neurol 1996;39:548-51.
3. Braak H, Braak E. Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder. Neurobiol Aging 1994;15:355-6.
4. Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand 1996;165:3-12.
5. Corder EH, Saunders AM, Pericak-Vance MA, Roses AD. There is a pathologic relationship between ApoE-∈4 and Alzheimer's disease. Arch Neurol 1995;52:650.
6. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
7. Crystal H, Dickson D, Fuld P, et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988;38:1682-7.
8. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
9. Farrer LA, Cupples A, van Duijn CM, et al. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol 1995;38:797-803.
10. Förstl H, Czech C, Sattel H, et al. Apolipoprotein E und Alzheimer-Demenz. Nervenarzt 1994;65:780-6.
11. Gomez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E ∈4 in Alzheimer's disease. Ann Neurol 1996;39:62-70.
12. Greenberg SM, Rebeck GW Vonsattel J-PG, Gomez-Isla T, Hyman BT. Apolipoprotein E ∈4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:254-9.
13. Heinonen O, Lehtovirta M, Soininen H, et al. Alzheimer pathology of patients carrying apolipoprotein E ∈4 allele. Neurobiol Aging 1995;16:505-13.
14. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha1. J Lipid Res 1990;31:345-8.
15. Hyman BT, West HL, Rebeck GW, et al. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci USA 1995;92:3586-90.
16. Itoh Y, Yamada M. Apolipoprotein E and the neuropathology of dementia. N Engl J Med 1996;334:599-600.
17. Itoh Y, Yamada M, Suematsu N, Matsushita M, Otomo E. Influence of apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly. Stroke 1996;27:216-8.
18. Katzman R, Terry R, DeTeresa R, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988;23:138-44.
19. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-105.
20. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invent 1987;57:230-6.
21. Korek G, Martin H, Wenzelides K. A modified method for the detection of nucleolar organizer regions (AgNORs). Acta Histochem 1991;90:155-7.
22. Kurz A, Lautenschlager N, Haupt M, et al. Das Apolipoprotein E-∈4-Allel ist ein Risikofaktor für die Alzheimer'sche Krankheit mit frühem und spätem Beginn. Nervenarzt 1994;65:774-9.
23. LaDu M, Falduto M, Manelli A, Reardon C, Getz G, Frail D. Isoform-specific binding of apolipoprotein E for β-amyloid. J Biol Chem 1994;269:23403-6.
24. Lehtovirta M, Laakso MP, Soininen H, et al. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 1995;67:65-72.
25. Lovestone S, Anderton BH, Hartley C, Jensen TG, Jorgensen AL. The intracellular fate of apolipoprotein E is tau dependent and apoe allele-specific. NeuroReport 1996;7:1005-8.
26. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-proteins into filaments. Nature 1994;372:92-4.
27. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995;37:254-9.
28. Menzel H-J, Kladetzky R-G, Assmann G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 1983;3:310-15.
29. Morris CM, Benjamin R, Leake A, et al. Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians. Neurosci Lett 1995;201:45-8.
30. Morris JC, Storandt M, McKeel DW, et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-19.
31. Muramatsu T, Higachi S, Arai H, et al. Apolipoprotein E ∈4 allele distribution in alcoholic dementia and in Alzheimer's disease in Japan. Ann Neurol 1994;36:797-9.
32. Nagy Z, Esiri MM, Jobst KA, et al. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 1995;69:757-61.
33. Näslund J, Thyberg J, Tjernberg LO, et al. Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. Neuron 1995;15:219-28.
34. Ohm TG, Kirca M, Bohl J, Scharnagl H, Groβ W, März W. Apolipoprotein E polymorphism influences not only cerebral plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 1995;66:583-7.
35. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
36. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995;333:1242-7.
37. Premkumar DRD, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E-∈4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996;148:2083-95.
38. Price JL. The relationship between tangle and plaque formation during healthy aging and mild dementia. Neurobiol Aging 1993;14:661-3.
39. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-80.
40. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the ∈4 allele for apolipoprotein E. N Engl J Med 1996;334:752-8.
41. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
42. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptides deposition as a consequence of apolipoprotein E genotype in late onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-53.
43. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 1995;92:4725-7.
44. Strittmatter WJ, Saunders AM, Goedert M, et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci USA 1994;91:11183-6.
45. Walker LC, Warzok R, Dünnewald S, et al. Apolipoprotein ∈4 promotes early β-amyloid deposition in the nondemented elderly. Soc Neurosci Abstr 1996;22:1696.
46. Wisniewski T, Castaño EM, Golabek A, Vogel T, Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 1994;145:1030-5.
47. Zhou Z, Smith JD, Greengard P, Gandy S. Alzheimer amyloid-β peptide forms denaturant-resistant complex with type ∈3 but not type ∈4 isoform of native apolipoprotein. Mol Med 1996;2.175-80.